# A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome

> **NCT06973304** · PHASE3 · RECRUITING · sponsor: **Takeda** · enrollment: 13 (estimated)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** Teduglutide

## Key facts

- **NCT ID:** NCT06973304
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-26
- **Primary completion:** 2027-02-10
- **Final completion:** 2027-07-28
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06973304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06973304, "A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06973304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*